See more : Jahwa Electronics. Co., Ltd (033240.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Mabion S.A. (MAB.WA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mabion S.A., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Aeso Holding Limited (8341.HK) Income Statement Analysis – Financial Results
- Verses Technologies Inc. (VRSSF) Income Statement Analysis – Financial Results
- Japan Business Systems, Inc. (5036.T) Income Statement Analysis – Financial Results
- Carasso Real Estate Ltd (CRSR.TA) Income Statement Analysis – Financial Results
- Torrent Power Limited (TORNTPOWER.BO) Income Statement Analysis – Financial Results
Mabion S.A. (MAB.WA)
About Mabion S.A.
Mabion S.A., a biotechnology company, engages in the development of various biotech drugs based on monoclonal antibody technology in Poland. The company develops, produces, and sells medicines for the treatment of neoplastic, autoimmune, metabolic, and neurological diseases. Its products include MabionCD20 and MabionHER2. The company was founded in 2007 and is based in Konstantynów Lódzki, Poland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 151.68M | 163.98M | 56.87M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.73M | 829.70K | 5.80K | 884.78K | 985.38K | 1.53M | 0.00 |
| Cost of Revenue | 37.10M | 98.00M | 20.99M | 9.83M | 466.00K | 797.00K | 971.00K | 758.00K | 5.64M | 4.22M | 6.00K | 1.84M | -7.00M | -1.18M | 5.98K |
| Gross Profit | 114.58M | 65.99M | 35.89M | -9.83M | -466.00K | -797.00K | -971.00K | -758.00K | -2.91M | -3.39M | -200.00 | -956.22K | 7.99M | 2.70M | -5.98K |
| Gross Profit Ratio | 75.54% | 40.24% | 63.10% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -106.29% | -408.74% | -3.45% | -108.07% | 810.76% | 177.05% | 0.00% |
| Research & Development | 6.25M | 15.12M | 13.60M | 35.73M | 40.71M | 44.93M | 43.26M | 44.22M | 37.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 40.18M | 28.66M | 10.99M | 7.95M | 3.63M | 3.22M | 7.07M | 3.18M | 5.18M | 1.09M | 4.05M | 1.13M | 7.88M | 93.06K | 23.14K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -988.00K | 309.00K | 186.00K | 166.00K | 0.00 | 0.00 | 0.00 |
| SG&A | 40.18M | 28.66M | 10.99M | 7.95M | 3.63M | 3.22M | 7.07M | 3.18M | 4.19M | 1.40M | 4.24M | 1.30M | 7.88M | 93.06K | 23.14K |
| Other Expenses | 13.10M | -4.29M | 18.98M | 10.97M | 18.25M | 16.03M | 12.05M | 8.28M | -6.81M | -5.42M | -4.01M | -3.25M | 1.97M | 2.23M | 360.65K |
| Operating Expenses | 59.52M | 39.49M | 43.58M | 54.65M | 62.59M | 63.38M | 61.41M | 54.92M | -6.81M | -5.42M | -4.01M | -3.25M | 9.86M | 2.33M | 383.80K |
| Cost & Expenses | 96.62M | 137.49M | 64.56M | 54.65M | 63.05M | 64.18M | 62.38M | 55.68M | -6.81M | -5.42M | -4.01M | -3.25M | 2.85M | 1.15M | 389.78K |
| Interest Income | 718.00K | 287.00K | 405.00K | 34.00K | 582.00K | 915.00K | 31.00K | 25.00K | 29.00K | 0.00 | 0.00 | 0.00 | 677.07K | 126.47K | 0.00 |
| Interest Expense | 1.04M | 1.70M | 1.29M | 1.41M | 751.00K | 1.92M | 1.72M | 217.00K | 235.00K | 0.00 | 0.00 | 0.00 | 77.25K | -2.72K | 0.00 |
| Depreciation & Amortization | 7.20M | 8.98M | 8.85M | 9.83M | 11.11M | 10.66M | 8.05M | 6.94M | 6.81M | 5.42M | 4.01M | 3.25M | 718.03K | 83.40K | 8.03K |
| EBITDA | 58.31M | 32.95M | 118.00K | -44.27M | -51.79M | -55.76M | -47.90M | -48.66M | -37.65M | 830.00K | 5.80K | 884.80K | -544.53K | 460.35K | -357.40K |
| EBITDA Ratio | 38.45% | 18.90% | 4.89% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | -116.68% | 30.14% | 0.00% |
| Operating Income | 55.06M | 22.02M | -6.07M | -54.65M | -63.27M | -64.63M | -62.38M | -55.53M | -4.08M | -4.59M | -4.01M | -2.36M | -1.87M | 376.95K | -389.78K |
| Operating Income Ratio | 36.30% | 13.43% | -10.66% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -149.29% | -553.07% | -69,089.66% | -267.14% | -189.54% | 24.68% | 0.00% |
| Total Other Income/Expenses | -5.17M | -6.18M | -423.00K | -1.12M | -466.00K | -2.39M | 4.49M | -295.00K | -443.00K | 115.00K | 129.10K | 189.90K | 599.82K | 129.19K | -8.06K |
| Income Before Tax | 49.89M | 22.04M | -10.26M | -55.77M | -63.74M | -68.87M | -57.89M | -55.83M | -4.52M | -4.53M | -3.88M | -2.17M | -1.27M | 506.14K | -397.84K |
| Income Before Tax Ratio | 32.89% | 13.44% | -18.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -165.50% | -546.43% | -66,863.79% | -245.68% | -128.67% | 33.13% | 0.00% |
| Income Tax Expense | 8.63M | -1.15M | -12.16M | 1.42M | 970.00K | -2.77M | 6.21M | 70.00K | -6.74M | -5.49M | -4.00M | -3.30M | 86.14K | 34.69K | -69.09K |
| Net Income | 41.27M | 23.19M | 1.90M | -57.19M | -64.71M | -68.87M | -57.89M | -55.83M | -4.60M | -4.46M | -3.89M | -2.12M | -1.35M | 471.45K | -328.75K |
| Net Income Ratio | 27.21% | 14.14% | 3.35% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -168.20% | -537.69% | -67,089.66% | -239.77% | -137.41% | 30.86% | 0.00% |
| EPS | 2.55 | 1.44 | 0.12 | -4.17 | -4.72 | -5.26 | -4.91 | -4.84 | -0.42 | -0.44 | -0.49 | -0.40 | -0.28 | 0.07 | -0.05 |
| EPS Diluted | 2.55 | 1.44 | 0.12 | -4.17 | -4.72 | -5.26 | -4.91 | -4.84 | -0.42 | -0.44 | -0.49 | -0.40 | -0.28 | 0.07 | -0.05 |
| Weighted Avg Shares Out | 16.16M | 16.16M | 15.56M | 13.72M | 13.72M | 13.09M | 11.80M | 11.54M | 10.88M | 10.06M | 7.93M | 5.33M | 4.88M | 6.90M | 6.90M |
| Weighted Avg Shares Out (Dil) | 16.16M | 16.16M | 15.56M | 13.72M | 13.72M | 13.09M | 11.80M | 11.55M | 10.88M | 10.06M | 7.93M | 5.33M | 4.88M | 6.90M | 6.90M |
No news found for: MAB.WA
Source: https://incomestatements.info
Category: Stock Reports